Endocrine therapy use and cardiovascular risk in postmenopausal breast cancer survivors.

Anthony A MatthewsSharon Peacock HintonSusannah StanwayAlexander Richard LyonLiam SmeethJennifer L LundKrishnan Bhaskaran

Published in: Heart (British Cardiac Society) (2020)

Higher risks of several cardiovascular outcomes among AI compared with tamoxifen users appeared to be driven by protective effects of tamoxifen, rather than cardiotoxic effects of AIs.

Keyphrases

breast cancer cells
estrogen receptor
positive breast cancer
artificial intelligence
bone mineral density
human health
stem cells